'con

Conferences
 

 

Hepatitis C Virus |West Nile Virus |Human Immunodeficiency Virus |HCV: The Chimeric Mouse Model
Antivirals for Biodefense | Virus-host Interactions|Host Defense |Therapeutic Application |Innate Immune Effector Genes

Innate Immunity to Hepatitis C: The Chimeric Mouse Model

This program brings together three groups of excellence in HCV research to define the parameters of virus and host immune regulation that control the outcome of HCV infection. The design of each project includes both unique studies and strong interactions with other projects. This, with facilitation from an administrative core, derives a central collaborative effort to define and validate novel virus/host interactions that can serve as a basis for immunomodulatory therapeutic strategies to control HCV infection and spread. With the recent development and characterization of a small animal model (the chimeric mouse) for the study of HCV infection there now exists a suitable and manageable in vivo system for molecular/genetic and immunologic analysis of HCV infection.

Gale Laboratory
Dr. Michael Gale, Jr., Investigator
  Dr. D. Lorne Tyrrell, Investigator
 
Diagram illustrates uniqueness of projects, areas of collaboration, and strong interactions between three centers of excellence.


UNIVERSITY OF WASHINGTON